Committee Member | Employment | Consultant | Speakers Bureau | Ownership/ Partnership/ Principal | Personal Research | Institutional, Organizational, or Other Financial Benefit | Expert Witness |
---|---|---|---|---|---|---|---|
Ty J. Gluckman (Co-Chair) | Providence Heart Institute Providence St. Joseph Health—Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS) |
None | None | None | None | None | None |
Nicole M. Bhave (Co-Chair) | University of Michigan Medical School—Associate Professor of Medicine Cardiovascular Medicine |
None | None | None | None | None | None |
Larry A. Allen (Vice Chair) | University of Colorado School of Medicine—Professor of Medicine; Kenneth Poirier Chair; Associate Head for Clinical Affairs, Cardiology Medical Director, Advanced Heart Failure |
|
None | None | None | None | None |
Eugene H. Chung (Vice Chair) | University of Michigan Medical School—Professor of Medicine; Director, Sports Cardiology Clinic | None | None | None | None | None | None |
Erica S. Spatz (Vice Chair) | Yale University School of Medicine—Associate Professor, Section of Cardiovascular Medicine; Director, Preventive Cardiovascular Health Program | None | None | None | None | None | None |
Enrico Ammirati | Niguarda Hospital, Milan, Italy—Cardiologist, Advanced Heart Failure, LVAD and Cardiac Transplant | None | None | None | None |
|
None |
Aaron L. Baggish | Massachusetts General Hospital—Cardiovascular Performance Program Director | None | None | None | None | None | None |
Biykem Bozkurt | Baylor College of Medicine—The Mary and Gordon Cain Chair and Professor of Medicine; Associate Provost of Faculty Affairs; Senior Associate Dean of Faculty Development; Director, Winters Center for Heart Failure Research; Associate Director, Cardiovascular Research Institute; Vice-Chair of Medicine |
|
None | None | None |
|
None |
William K. Cornwell, III | University of Colorado Anschutz Medical Campus—Cardiologist, Advanced Heart Failure, LVAD and Cardiac Transplant | None | None | None | None | None | None |
Kimberly G. Harmon | University of Washington—Team Physician | None | None | None | None | None | None |
Jonathan H. Kim | Emory Clinical Cardiovascular Research Institute, Emory School of Medicine—Associate Professor of Medicine, Director of Sports Cardiology | None | None | None | None | None | None |
Anuradha Lala | Icahn School of Medicine at Mount Sinai—Associate Professor, Cardiology & Population Health Science; Program Director, Advanced Heart Failure & Transplant Fellowship | None | None | None | None | None | None |
Benjamin D. Levine | Institute for Exercise & Environmental Medicine—Director; Texas Health Presbyterian Dallas—Chair for Wellness and Chair for Cardiovascular Research; The University of Texas Southwestern Medical Center—Professor of Medicine and Cardiology | None | None |
|
None | None | None |
Matthew M. Martinez | Morristown Medical Center—Director Sports Cardiology and Hypertrophic Cardiomyopathy Center |
|
None | None | None | None | None |
Oyere Onuma | Yale University School of Medicine— Assistant Professor of Cardiology | None | None | None | None | None | None |
Dermot Phelan | Sanger Heart and Vascular Institute, Atrium Health—Director of Sports Cardiology |
|
None | None | None | None | None |
Valentina O. Puntmann | University Hospital Frankfurt—Associate Professor, Consultant Cardiologist (Cardiovascular Magnetic Resonance Imaging) |
|
None | None | None | None | None |
Saurabh Rajpal | The Ohio State University Wexner Medical Center—Assistant Professor | None | None | None | None | None | None |
Pam R. Taub | University of California San Diego Medical Center—Professor of Medicine; Director of Step Family Foundation Cardiovascular Rehabilitation and Wellness Center |
|
None | None | None | None | None |
Amanda K. Verma | Washington University School of Medicine—Assistant Professor of Medicine, Advanced Heart Failure and Transplant Cardiology; Director of COVID Cardiology Clinics | None | None | None | None | None | None |
This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted.
According to the ACC, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.
ACC = American College of Cardiology; LVAD = left ventricular assist device.
Significant relationship.